Lyell Immunopharma
LYEL
LYEL
59 hedge funds and large institutions have $165M invested in Lyell Immunopharma in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
14% less funds holding
Funds holding: 69 → 59 (-10)
71% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 14
88% less call options, than puts
Call options by funds: $47K | Put options by funds: $405K
Holders
59
Holding in Top 10
9
Calls
$47K
Puts
$405K
Top Buyers
| 1 | +$10.7M | |
| 2 | +$3.84M | |
| 3 | +$835K | |
| 4 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
+$804K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$779K |
Top Sellers
| 1 | -$3.35M | |
| 2 | -$870K | |
| 3 | -$444K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$350K |
| 5 |
Walleye Capital
New York
|
-$258K |
